Foresite Capital Management Vi LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0002013341

Type: FundHoldings: 14Value: $182.5MLatest: 2025Q1

Foresite Capital Management VI LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 14 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "EWTX",
  "CNTA",
  "BCAX",
  "ALLO",
  "GPCR",
  "KYMR",
  "ALMS",
  null,
  "RAPT",
  "CRVS",
  "VRDN",
  "CGON",
  "CGEM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 14
Total Value: 182545373
Accession Number: 0001104659-25-049404
Form Type: 13F-HR
CIK: foresite-capital-management-vi
Manager Name: Foresite-Capital-Management-Vi

Data Enrichment

93% identified

13 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

14 positions • $182.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

CG Oncology, Inc.

CGON|156944100

Shares:2.2M

Value:$54.4M

% of Portfolio:29.8% ($54.4M/$182.5M)

ALUMIS INC.

ALMS|022307102

Shares:4.2M

Value:$25.8M

% of Portfolio:14.1% ($25.8M/$182.5M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:1.3M

Value:$18.0M

% of Portfolio:9.9% ($18.0M/$182.5M)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:12.5M

Value:$15.3M

% of Portfolio:8.4% ($15.3M/$182.5M)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:365.0K

Value:$14.8M

% of Portfolio:8.1% ($14.8M/$182.5M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:585.0K

Value:$12.9M

% of Portfolio:7.1% ($12.9M/$182.5M)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:950.0K

Value:$12.4M

% of Portfolio:6.8% ($12.4M/$182.5M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:420.0K

Value:$7.3M

% of Portfolio:4.0% ($7.3M/$182.5M)

Allogene Therapeutics, Inc.

ALLO|019770106

Shares:3.4M

Value:$5.0M

% of Portfolio:2.8% ($5.0M/$182.5M)

Corvus Pharmaceuticals, Inc.

CRVS|221015100

Shares:1.6M

Value:$5.0M

% of Portfolio:2.8% ($5.0M/$182.5M)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:634.6K

Value:$4.8M

% of Portfolio:2.6% ($4.8M/$182.5M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:146.3K

Value:$4.0M

% of Portfolio:2.2% ($4.0M/$182.5M)

G1933S101

Shares:1.3M

Value:$2.9M

% of Portfolio:1.6% ($2.9M/$182.5M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:2.0K

Value:$26.6K

% of Portfolio:0.0% ($26.6K/$182.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
CG Oncology, Inc.(CGONcusip156944100)	2.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$54.4M	29.8% ($54.4M/$182.5M)	QoQ -14.60% (-$9.3M) YoY-
ALUMIS INC.(ALMScusip022307102)	4.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$25.8M	14.1% ($25.8M/$182.5M)	QoQ -21.88% (-$7.2M) YoY-
Centessa Pharmaceuticals plc(CNTAcusip152309100)	1.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$18.0M	9.9% ($18.0M/$182.5M)	QoQ -14.14% (-$3.0M) YoY-
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	12.5M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$15.3M	8.4% ($15.3M/$182.5M)	QoQ -22.78% (-$4.5M) YoY-
Akero Therapeutics, Inc.(AKROcusip00973Y108)	365.0K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$14.8M	8.1% ($14.8M/$182.5M)	QoQ +45.50% (+$4.6M) YoY-
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	585.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$12.9M	7.1% ($12.9M/$182.5M)	QoQ -17.60% (-$2.7M) YoY-
Bicara Therapeutics Inc.(BCAXcusip055477103)	950.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$12.4M	6.8% ($12.4M/$182.5M)	QoQ -25.20% (-$4.2M) YoY-
Structure Therapeutics Inc.(GPCRcusip86366E106)	420.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$7.3M	4.0% ($7.3M/$182.5M)	QoQ -36.17% (-$4.1M) YoY-
Allogene Therapeutics, Inc.(ALLOcusip019770106)	3.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$5.0M	2.8% ($5.0M/$182.5M)	QoQ -31.45% (-$2.3M) YoY-
Corvus Pharmaceuticals, Inc.(CRVScusip221015100)	1.6M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$5.0M	2.8% ($5.0M/$182.5M)	QoQ -40.56% (-$3.4M) YoY-
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	634.6K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$4.8M	2.6% ($4.8M/$182.5M)	QoQ -37.84% (-$2.9M) YoY-
Kymera Therapeutics, Inc.(KYMRcusip501575104)	146.3K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$4.0M	2.2% ($4.0M/$182.5M)	QoQ -31.96% (-$1.9M) YoY-
(cusipG1933S101)✕	1.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$2.9M	1.6% ($2.9M/$182.5M)	QoQ -23.67% (-$890.7K) YoY-
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	2.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$26.6K	0.0% ($26.6K/$182.5M)	QoQ -29.68% (-$11.2K) YoY-